http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7314762-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cf374ecaed27c8b9bd75d56acd7e801 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775 |
filingDate | 2001-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0da6ecf7ae806a6f373161634f44b4f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_419f93646f9d7076bb3bbf012f3ff2ea |
publicationDate | 2008-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-7314762-B2 |
titleOfInvention | Apolipoprotein biopolymer markers indicative of insulin resistance |
abstract | The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or the absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease. |
priorityDate | 2001-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.